1MAJ
| SOLUTION STRUCTURE OF AN ISOLATED ANTIBODY VL DOMAIN | Descriptor: | IGG2A-KAPPA 26-10 FV (LIGHT CHAIN) | Authors: | Constantine, K.L, Friedrichs, M.S, Metzler, W.J, Wittekind, M, Hensley, P, Mueller, L. | Deposit date: | 1993-09-16 | Release date: | 1994-01-31 | Last modified: | 2017-11-29 | Method: | SOLUTION NMR | Cite: | Solution structure of an isolated antibody VL domain. J.Mol.Biol., 236, 1994
|
|
1MAK
| SOLUTION STRUCTURE OF AN ISOLATED ANTIBODY VL DOMAIN | Descriptor: | IGG2A-KAPPA 26-10 FV (LIGHT CHAIN) | Authors: | Constantine, K.L, Friedrichs, M.S, Metzler, W.J, Wittekind, M, Hensley, P, Mueller, L. | Deposit date: | 1993-09-16 | Release date: | 1994-01-31 | Last modified: | 2017-11-29 | Method: | SOLUTION NMR | Cite: | Solution structure of an isolated antibody VL domain. J.Mol.Biol., 236, 1994
|
|
1AKP
| SEQUENTIAL 1H,13C AND 15N NMR ASSIGNMENTS AND SOLUTION CONFORMATION OF APOKEDARCIDIN | Descriptor: | APOKEDARCIDIN | Authors: | Constantine, K.L, Colson, K.L, Wittekind, M, Friedrichs, M.S, Zein, N, Tuttle, J, Langley, D.R, Leet, J.E, Schroeder, D.R, Lam, K.S, Farmer II, B.T, Metzler, W.J, Bruccoleri, R.E, Mueller, L. | Deposit date: | 1994-06-20 | Release date: | 1994-08-31 | Last modified: | 2024-10-16 | Method: | SOLUTION NMR | Cite: | Sequential 1H, 13C, and 15N NMR assignments and solution conformation of apokedarcidin. Biochemistry, 33, 1994
|
|
1PDC
| |
1PFL
| REFINED SOLUTION STRUCTURE OF HUMAN PROFILIN I | Descriptor: | PROFILIN I | Authors: | Metzler, W.J, Farmer II, B.T, Constantine, K.L, Friedrichs, M.S, Lavoie, T, Mueller, L. | Deposit date: | 1994-12-12 | Release date: | 1995-03-31 | Last modified: | 2024-05-01 | Method: | SOLUTION NMR | Cite: | Refined solution structure of human profilin I. Protein Sci., 4, 1995
|
|
1AH1
| CTLA-4, NMR, 20 STRUCTURES | Descriptor: | CTLA-4, beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose | Authors: | Metzler, W.J, Bajorath, J, Fenderson, W, Shaw, S.-Y, Peach, R, Constantine, K.L, Naemura, J, Leytze, G, Lavoie, T.B, Mueller, L, Linsley, P.S. | Deposit date: | 1997-04-11 | Release date: | 1998-04-15 | Last modified: | 2020-07-29 | Method: | SOLUTION NMR | Cite: | Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28. Nat.Struct.Biol., 4, 1997
|
|
4KNW
| |
4KNV
| The crystal structure of APO HUMAN HDHD4 FROM SE-MAD | Descriptor: | MAGNESIUM ION, N-acylneuraminate-9-phosphatase, PHOSPHATE ION | Authors: | Klei, H.E. | Deposit date: | 2013-05-10 | Release date: | 2013-06-26 | Last modified: | 2013-07-10 | Method: | X-RAY DIFFRACTION (1.993 Å) | Cite: | Design, synthesis, functional and structural characterization of an inhibitor of N-acetylneuraminate-9-phosphate phosphatase: Observation of extensive dynamics in an enzyme/inhibitor complex. Bioorg.Med.Chem.Lett., 23, 2013
|
|
1HCV
| |